Vistagen Therapeutics VTGN
NASDAQ VTGN
$0.18 -0.01 (-3.90%)
At close: Oct 23, 2026 · 4:00 PM EDT

Vistagen Therapeutics (VTGN) Amortization of Deferred Charges (2013 - 2017)

Updated

Vistagen Therapeutics (VTGN) posted Amortization of Deferred Charges of $146,300 for FY2018 (year ended Mar 31, 2018), up 74.8% from $83,700 in FY2017.

Analysis

Vistagen Therapeutics (VTGN) Amortization of Deferred Charges (2013 - 2017) Analysis & Trends

Since FY2015, Vistagen Therapeutics has reported Amortization of Deferred Charges for 4 fiscal years.

  • Business Quant data shows VTGN's Amortization of Deferred Charges at $83,700 in FY2017, -$27,500 in FY2016 and -$14,400 in FY2015.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn
10 Vistagen Therapeutics 7.74 Mn -208.34 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2017 83,700.00
Sep 30, 2015 14,000.00
Jun 30, 2015 550,800.00
Mar 31, 2015 2.08 Mn
Dec 31, 2014 495,700.00
Sep 30, 2014 317,100.00
Jun 30, 2014 481,900.00
Mar 31, 2014 283,900.00
Dec 31, 2013 154,100.00
Sep 30, 2013 108,000.00
Jun 30, 2013 94,000.00
Mar 31, 2013 -97,400.00
API Access

Vistagen Therapeutics Amortization of Deferred Charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=VTGN&period=max&api_key=YOUR_API_KEY